In this CMEO Snack, entitled Managing Cardiovascular Risk in Patients with Narcolepsy, expert faculty will discuss strategies for initiating and switching treatment plans for patients with narcolepsy that consider comorbidities, dosing, and titration strategies.
Dr. Anne Marie Morse is the Director of Child Neurology and Pediatric Sleep Medicine at Geisinger, Janet Weis Children’s Hospital. She has significant clinical and research experience and interest in children, adolescents, and adults with sleep wake disorders, particularly central disorders of hypersomnolence. In addition, her research interests extend more broadly to include investigating the relationship between sleep and neurologic and neurodevelopmental disorders. Dr Morse’s commitment to sleep health extends into the community. She has developed a school-based sleep education and surveillance program called Wake Up and Learn. This program was developed to provide education about sleep health and perform school-based sleep screening to improve recognition of pediatric sleep disorders in middle and high school students. It has now expanded to include learners in college, medical school, and medical residency programs with a clinical and health plan delivery, called Sleep to Be Well. Dr. Morse envisions a world where sleep can be acknowledged as the vital sign of health, wellness, and performance that it is designed to be.
Dr. Bogan is the President of Bogan Sleep Consultants, LLC. He is also Associate Clinical Professor at the University of South Carolina School of Medicine and Associate Clinical Professor at the Medical University of South Carolina in Charleston, SC.
Dr. Bogan received his bachelor’s degree in chemistry from Wofford College and his MD degree from the Medical University of South Carolina in Charleston. He served his internship and residency, as well as Chief Medical Resident, at the University of Alabama Hospital and Clinics in Birmingham. Thereafter, he completed a fellowship and assistant professorship in the Pulmonary Division of the Department of Medicine at the University of Alabama School of Medicine. He has been certified by the American boards of Sleep Medicine, Internal Medicine, and Pulmonary Diseases.
Dr. Bogan has served as principal investigator on numerous clinical trials in the past and continues to do so now. He has a variety of publications and research interests that focus on topics such as narcolepsy, insomnia, sleep apnea, shift work sleep disorder, restless legs syndrome/periodic limb movement disorder, chronic fatigue/fibromyalgia, and circadian rhythm abnormality.
In the second activity of this CME Outfitters Snack series, expert faculty will guide learners through an overview on the impact of climate change on the changing geographic prevalence of dengue disease as well as the importance, current limitations with, and unmet needs related to the single available vaccination against this viral illness.
Dr. Inés Esquilín Rivera is a professor at the Department of Pediatrics of the University of Puerto Rico School of Medicine and the director of the Division of Pediatric Infectious Diseases.
She obtained her doctorate degree in Medicine and Pediatrics at the University of Puerto Rico School of Medicine in 1989 and 1992, respectively. Subsequently, she completed a Pediatric Infectious Disease Fellowship at the Jackson Memorial Hospital affiliated with the University of Miami in Florida in 1995.
She is involved in clinical research projects involving vaccine development, epidemiology of arboviral diseases, HIV-related conditions, and antiretroviral medications.
Dr. Esquilín Rivera worked as the principal investigator of two phase II studies for investigational dengue vaccines from 2007 to 2017. The results of these studies were published in peer-reviewed journals and have multiple citations.
She was a member of the CDC ACIP Dengue Vaccines Workgroup from October 2018 to 2022 and works with the Puerto Rico Health Department in the development of strategies to facilitate dengue vaccination on the island. She has been a member of the WHO/PAHO Arboviral Group Advisory Board since 2017 and has participated in multiple educational activities related to the prevention of dengue and other arboviral diseases.
Prof. Sáfadi is the Head of the Department of Pediatrics at the School of Medical Sciences of Santa Casa de São Paulo and serves as the Coordinator of the post-graduation course on Health Sciences there. Following his medical degree and a residency in pediatrics, he continued his training in pediatric infectious diseases at the Federal University of São Paulo, receiving a master’s and a PhD degree.
Prof. Sáfadi has been a member of the Permanent Advisory Board on Immunization Practices for the Secretary of Health in the State of São Paulo and the Ministry of Health in Brazil for more than 10 years. He is the current Chairman of the Department of Immunization for the Society of Pediatrics, São Paulo as well as the Chairman of the Department of Infectious Diseases for the Brazilian Society of Pediatrics.
Prof. Sáfadi is an active member of several societies focusing on infectious diseases, including SLIPE, ESPID, and WSPID. He is also a member of the Steering Committee from the Global Meningococcal Initiative and a member of the Scientific Advisory Group of the Confederation of Meningitis Organisations (CoMO), which is part of the Meningitis Research Foundation. Prof. Sáfadi is an expert member of the SAGE Working Group on Meningococcal Vaccines and Vaccination from WHO and a liaison representative for the Brazilian NITAG in the SAGE Immunization Group from WHO. He was nominated as a member to the Coalition for Epidemic Preparedness Innovations (CEPI) Scientific Advisory Committee.
Prof. Sáfadi is a member of the editorial board from Jornal de Pediatria, Pneumonia BMC and The Journal of Pediatrics. Over the course of his career, he has made significant contributions to the field of infectious diseases, particularly in the areas of immunization, meningococcal and pneumococcal infections, congenital toxoplasmosis, influenza, rotavirus gastroenteritis, HPV, and community-acquired infections. He has published over 100 peer-reviewed articles and has presented his research at numerous international conferences. He is passionate about sharing his expertise with others and is committed to advancing the field through education and research.
In this CME Outfitters Snack, expert faculty will discuss ways to adapt guideline recommendations into practice for PLWH who seek to become pregnant, are pregnant, or are postpartum, including patient cases to illustrate best practices for caring for these unique patients and their particular needs.
Janeli Alejandra is a full-time working mother and wife who dabbles in stigma breaking. She’s been living with HIV for 13 years and uses social media to advocate for the destigmatizing of HIV. She and her husband use their social media accounts to help educate others on HIV testing, living and thriving with HIV, and giving birth while HIV+. All of Janeli’s children are HIV- , healthy, and living normal lives alongside their 3 dogs and HIV+ parents.
Florence Momplaisir, MD, MSHP, is an Assistant Professor in the Division of Infectious Diseases (ID) at the University of Pennsylvania, Perelman School of Medicine in Philadelphia, Pennsylvania. Dr. Momplaisir is also Vice Chief for Diversity, Equity, and Inclusion (DEI) in ID and Senior Fellow of the Penn Leonard Davis Institute of Health Economics. Her clinical research focuses on improving postpartum retention and viral suppression of pregnant and postpartum women living with HIV and on decreasing racial disparities in HIV prevalence among U.S. populations. She is currently the Principal Investigator (PI) for 3 Research Project Grants (R01) focusing on using peer-led and organizational-level behavioral interventions to improve HIV care continuum outcomes of people living with HIV. She is an expert panel member of the Health and Human Services (HHS) Perinatal HIV Treatment guidelines committee. Dr. Momplaisir serves as Co-Director of a Center For AIDS Research (CFAR) Scientific Working Group focused on using implementation science methods to end the HIV epidemic regionally. In this capacity, she fosters the growth of early career investigators interested in work at the intersection of HIV, HIV prevention, and implementation science research.
Martina L. Badell, MD is an Associate Professor in the Department of Gynecology and Obstetrics, Division of Maternal-Fetal Medicine at Emory University School of Medicine, with an interest in infectious diseases in pregnancy. Dr. Badell is the Director of the Emory Perinatal Centers, regional referral centers for high-risk pregnant women in Georgia. She is also the Director of the Grady Health System HIV in Pregnancy clinic. Additionally, Dr. Badell has guest researcher status at the Centers for Disease Control which has allowed her the opportunity to work with skilled research teams on the study of infectious diseases in pregnancy.
In the final activity of this CME Outfitters Snack, expert faculty will provide an overview of the latest efficacy and safety data for both current and emerging vaccinations against dengue disease as well as assist learners in the translation of this data into clinical practice.
Dr. Inés Esquilín Rivera is a professor at the Department of Pediatrics of the University of Puerto Rico School of Medicine and the director of the Division of Pediatric Infectious Diseases.
She obtained her doctorate degree in Medicine and Pediatrics at the University of Puerto Rico School of Medicine in 1989 and 1992, respectively. Subsequently, she completed a Pediatric Infectious Disease Fellowship at the Jackson Memorial Hospital affiliated with the University of Miami in Florida in 1995.
She is involved in clinical research projects involving vaccine development, epidemiology of arboviral diseases, HIV-related conditions, and antiretroviral medications.
Dr. Esquilín Rivera worked as the principal investigator of two phase II studies for investigational dengue vaccines from 2007 to 2017. The results of these studies were published in peer-reviewed journals and have multiple citations.
She was a member of the CDC ACIP Dengue Vaccines Workgroup from October 2018 to 2022 and works with the Puerto Rico Health Department in the development of strategies to facilitate dengue vaccination on the island. She has been a member of the WHO/PAHO Arboviral Group Advisory Board since 2017 and has participated in multiple educational activities related to the prevention of dengue and other arboviral diseases.
Prof. Sáfadi is the Head of the Department of Pediatrics at the School of Medical Sciences of Santa Casa de São Paulo and serves as the Coordinator of the post-graduation course on Health Sciences there. Following his medical degree and a residency in pediatrics, he continued his training in pediatric infectious diseases at the Federal University of São Paulo, receiving a master’s and a PhD degree.
Prof. Sáfadi has been a member of the Permanent Advisory Board on Immunization Practices for the Secretary of Health in the State of São Paulo and the Ministry of Health in Brazil for more than 10 years. He is the current Chairman of the Department of Immunization for the Society of Pediatrics, São Paulo as well as the Chairman of the Department of Infectious Diseases for the Brazilian Society of Pediatrics.
Prof. Sáfadi is an active member of several societies focusing on infectious diseases, including SLIPE, ESPID, and WSPID. He is also a member of the Steering Committee from the Global Meningococcal Initiative and a member of the Scientific Advisory Group of the Confederation of Meningitis Organisations (CoMO), which is part of the Meningitis Research Foundation. Prof. Sáfadi is an expert member of the SAGE Working Group on Meningococcal Vaccines and Vaccination from WHO and a liaison representative for the Brazilian NITAG in the SAGE Immunization Group from WHO. He was nominated as a member to the Coalition for Epidemic Preparedness Innovations (CEPI) Scientific Advisory Committee.
Prof. Sáfadi is a member of the editorial board from Jornal de Pediatria, Pneumonia BMC and The Journal of Pediatrics. Over the course of his career, he has made significant contributions to the field of infectious diseases, particularly in the areas of immunization, meningococcal and pneumococcal infections, congenital toxoplasmosis, influenza, rotavirus gastroenteritis, HPV, and community-acquired infections. He has published over 100 peer-reviewed articles and has presented his research at numerous international conferences. He is passionate about sharing his expertise with others and is committed to advancing the field through education and research.
In the final activity of this CME Outfitters Snack series, expert faculty will help learners to identify opportunities to integrate effective and inclusive SDM into their clinical practice and implement patient-centered treatment plans for patients with uterine fibroids.
Tanika Gray Valbrun is an award-winning journalist, educator, and non-profit founder with a passion for women’s health. After her personal struggles with uterine fibroids, including two myomectomies, Tanika’s passion for women’s health inspired her to create The White Dress Project, a non-profit organization dedicated to providing support for women suffering from fibroids and to raise awareness through fibroid education. As the founder of The White Dress Project, Tanika has successfully worked with doctors, health advocates, and elected officials across the country to get legislation passed declaring July as “Fibroids Awareness Month.” Recognized as a thought leader and patient advocate for uterine health, she has also spoken around the world encouraging women to be their own best health advocate. Many women with symptomatic fibroids never dream of wearing white because of their heavy menstrual bleeding or bloating. The white dress is a “symbol of hope” that women with fibroids can feel supported and know that they do not have to suffer in silence. In addition to encouraging women to be their own health advocates, Tanika works as a senior content producer for a global news organization where she has been awarded three coveted Peabody Awards for her contributions in journalism.
Nisha McKenzie is the founder and owner of the Women’s+ Health Collective in Grand Rapids, MI. She graduated in 2002 with a master’s in medicine – Physician Assistant studies. Since that time, she has dedicated her career to women’s health, sexual health, hormones, and survivorship. Beginning in 2011, she intently focused on women’s sexual health and its relation to overall health. She completed the University of Michigan Sexual Health Certificate Program in cohort 2014. She is a Nationally Certified Menopause Practitioner and a Fellow of the International Society for the Study of Women’s Sexual Health. Nisha teaches both sexual medicine and gynecology for the Grand Valley State University PA Program and the Western Michigan University PA Program. She also regularly precepts PA, NP, and medical students as well as licensed medical professionals. She speaks at medical and therapy conferences across the country with a dedication to helping providers understand how to better include sexual health into general health as well as how to break down gender bias in medicine.
Dr. Ayman Al-Hendy is currently a tenured professor and Vice Chair of Research in the Department of Obstetrics and Gynecology, as well as advisor to the Dean of Medicine at Pritzker School of Medicine, University of Chicago (UC). Dr. Al-Hendy is a gynecologist and endoscopic surgeon at UC Medical Center in Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. Dr. Al-Hendy’s medical research interests focus on developing novel therapies, including gene and stem cell therapy, for premature ovarian insufficiency, endometriosis, and particularly uterine fibroids. Dr. Al-Hendy has published more than 242 peer-reviewed publications in high-tier scientific journals, participated in more than 360 presentations in national and international meetings, and edited 5 medical books. Dr. Al-Hendy has also been elected as the 71st President of the Society for Reproductive Investigation.
In the third activity of this CME Outfitters Snack series, expert faculty will provide an overview of the various treatment options for uterine fibroids and help learners to integrate clinical management guidelines for this condition into clinical practice.
Dr. Andrea Lukes established the Carolina Women’s Research and Wellness Center in 2008. She received her bachelor’s degree in religion from Duke University, followed by a combined medical degree and master’s degree in biostatistics from Duke University. After completing her residency at University of North Carolina, she worked at Duke University Medical Center (DUMC) for 10 years. While at DUMC, Dr. Lukes co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic. She has participated in research programs supported by the National Institutes of Health and Centers for Disease Control and Prevention and has conducted multiple industry-sponsored US Food and Drug Administration (FDA) trials. Since 2017, Dr. Lukes has also served as the Chief Medical Officer at a woman-focused clinical research organization in Durham, North Carolina. She continues to actively consult with industry regarding the development and implementation of research protocols, including communications and presentations to the FDA. To date, she has participated in over 130 FDA-approved clinical studies.
Dr. Ayman Al-Hendy is currently a tenured professor and Vice Chair of Research in the Department of Obstetrics and Gynecology, as well as advisor to the Dean of Medicine at Pritzker School of Medicine, University of Chicago (UC). Dr. Al-Hendy is a gynecologist and endoscopic surgeon at UC Medical Center in Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. Dr. Al-Hendy’s medical research interests focus on developing novel therapies, including gene and stem cell therapy, for premature ovarian insufficiency, endometriosis, and particularly uterine fibroids. Dr. Al-Hendy has published more than 242 peer-reviewed publications in high-tier scientific journals, participated in more than 360 presentations in national and international meetings, and edited 5 medical books. Dr. Al-Hendy has also been elected as the 71st President of the Society for Reproductive Investigation.